Charles J. Ryan, MD | Authors

Articles

Use of ARN-509 in Prostate Cancer

May 28, 2015

Charles J. Ryan, MD, Professor of Clinical Medicine, Urology, Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), discusses the use of ARN-509 and its efficacy in treating prostate cancer.